{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:28:43Z","timestamp":1781897323499,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.taap.2025.117391","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:09:22Z","timestamp":1746817762000},"page":"117391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Repurposing of cabergoline to improve cognitive decline in D-galactose-injected ovariectomized rats: Modulation of AKT\/mTOR, GLT-1\/P38-MAPK, and ERK1\/2 signaling pathways"],"prefix":"10.1016","volume":"500","author":[{"given":"Sheer A.","family":"Joodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weam W.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.taap.2025.117391_bb0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"Angelucci","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.taap.2025.117391_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12035-011-8209-x","article-title":"Genetic approaches to investigate the role of CREB in neuronal plasticity and memory","volume":"44","author":"Barco","year":"2011","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.taap.2025.117391_bb0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.taap.2025.117391_bb0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2011.11.009","article-title":"Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer\u2019s disease therapeutics","volume":"83","author":"Bitner","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.taap.2025.117391_bb0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2025.117391_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","article-title":"The glutamatergic system and Alzheimer\u2019s disease: therapeutic implications","volume":"17","author":"Butterfield","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.taap.2025.117391_bb0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"Activation of mTOR: a culprit of Alzheimer\u2019s disease?","author":"Cai","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.taap.2025.117391_bb0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2008.12.022","article-title":"Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor","volume":"66","author":"Carnicella","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.taap.2025.117391_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-010-1894-8","article-title":"Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling","volume":"211","author":"Chiba","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.taap.2025.117391_bb0050","series-title":"Handbook of Histopathological and Histochemical Techniques: Including Museum Techniques","author":"Culling","year":"2013"},{"key":"10.1016\/j.taap.2025.117391_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12017-011-8154-x","article-title":"Brain-derived neurotrophic factor and Alzheimer\u2019s disease: physiopathology and beyond","volume":"13","author":"Diniz","year":"2011","journal-title":"NeuroMolecular Med."},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/FBP.0000000000000407","article-title":"Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: possible role of glutamatergic pathway and oxidative stress","volume":"30","author":"Ekladious","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.taap.2025.117391_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/472932","article-title":"Antioxidant therapies for Alzheimer's disease","volume":"2012","author":"Feng","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.taap.2025.117391_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8501693","article-title":"Current research therapeutic strategies for Alzheimer\u2019s disease treatment","volume":"2016","author":"Folch","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.taap.2025.117391_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fneur.2018.00236","article-title":"Neuromodulatory effect of thymoquinone in attenuating glutamate-mediated neurotoxicity targeting the amyloidogenic and apoptotic pathways","volume":"9","author":"Fouad","year":"2018","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.taap.2025.117391_bb0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.taap.2025.117391_bb0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2004.02527.x","article-title":"Neuronal expression of myeloperoxidase is increased in Alzheimer\u2019s disease","volume":"90","author":"Green","year":"2004","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.taap.2025.117391_bb0090","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1046\/j.1460-9568.2000.00164.x","article-title":"\u0392-Amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis","volume":"12","author":"Harkany","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.taap.2025.117391_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.22319","article-title":"Apomorphine treatment in Alzheimer mice promoting amyloid-\u03b2 degradation","volume":"69","author":"Himeno","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0100","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1038\/s41598-019-46558-1","article-title":"Escitalopram ameliorates cognitive impairment in D-galactose-injected ovariectomized rats: modulation of JNK, GSK-3\u03b2, and ERK signalling pathways","volume":"9","author":"Ibrahim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117391_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115028","article-title":"Cognitive enhancing effect of diapocynin in D-galactose-ovariectomy-induced Alzheimer\u2019s-like disease in rats: role of ERK, GSK-3\u03b2, and JNK signaling","volume":"398","author":"Ibrahim","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2025.117391_bb0110","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s10787-022-00973-5","article-title":"Dapagliflozin as an autophagic enhancer via LKB1\/AMPK\/SIRT1 pathway in ovariectomized\/d-galactose Alzheimer\u2019s rat model","volume":"30","author":"Ibrahim","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2025.117391_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110239","article-title":"NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy\/D-galactose Alzheimer\u2019s disease rat model","volume":"119","author":"Ibrahim","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/156720209787466028","article-title":"Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways","volume":"6","author":"Islam","year":"2009","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.taap.2025.117391_bb0125","first-page":"1","article-title":"Drugs repurposing in the experimental models of Alzheimer\u2019s disease","author":"Joodi","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2025.117391_bb0130","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1007\/s12035-018-0966-3","article-title":"Stimulation of ACE2\/ANG (1\u20137)\/mas axis by diminazene ameliorates Alzheimer\u2019s disease in the D-galactose-ovariectomized rat model: role of PI3K\/Akt pathway","volume":"55","author":"Kamel","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.taap.2025.117391_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11062-019-09823-7","article-title":"Altered neurochemistry in Alzheimer\u2019s disease: targeting neurotransmitter receptor mechanisms and therapeutic strategy","volume":"51","author":"Kaur","year":"2019","journal-title":"Neurophysiology"},{"key":"10.1016\/j.taap.2025.117391_bb0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S0482-50042012000300016","article-title":"Description of a new method of ovariectomy in female rats","volume":"52","author":"Khajuria","year":"2012","journal-title":"Rev. Bras. Reumatol."},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Translational Neurodegeneration"},{"issue":"11","key":"10.1016\/j.taap.2025.117391_bb0150","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/npp.2014.119","article-title":"Dopaminergic modulation of cortical plasticity in Alzheimer\u2019s disease patients","volume":"39","author":"Koch","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.taap.2025.117391_bb0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"cell"},{"issue":"10","key":"10.1016\/j.taap.2025.117391_bb0160","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid \u03b2 peptide load is correlated with increased \u03b2-secretase activity in sporadic Alzheimer\u2019s disease patients","volume":"101","author":"Li","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"36","key":"10.1016\/j.taap.2025.117391_bb0165","doi-asserted-by":"crossref","first-page":"39329","DOI":"10.18632\/oncotarget.5744","article-title":"Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2025.117391_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175443","article-title":"Dopamine D2 receptor agonist bromocriptine ameliorates A\u03b21-42-induced memory deficits and neuroinflammation in mice","volume":"938","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.taap.2025.117391_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"methods"},{"issue":"2","key":"10.1016\/j.taap.2025.117391_bb0180","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.taap.2025.117391_bb0185","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/cercor\/bhq002","article-title":"Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs\/RAGE\/NF-\u03baB pathway activation","volume":"20","author":"Lu","year":"2010","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(02)00057-X","article-title":"Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis","volume":"24","author":"Lyness","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"22","key":"10.1016\/j.taap.2025.117391_bb0195","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.3390\/ijms20225674","article-title":"Excitatory amino acid transporters (EAATs): glutamate transport and beyond","volume":"20","author":"Magi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.taap.2025.117391_bb0200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4103\/1673-5374.332132","article-title":"Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer\u2019s disease","volume":"17","author":"Mansour","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.taap.2025.117391_bb0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.taap.2025.117391_bb0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.euroneuro.2005.08.003","article-title":"Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury","volume":"16","author":"Micale","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.taap.2025.117391_bb0215","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1248\/bpb.19.1499","article-title":"Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine-treated rodents","volume":"19","author":"Miyagi","year":"1996","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0225","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.taap.2025.117391_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099271","article-title":"Cabergoline, dopamine D2 receptor agonist, prevents neuronal cell death under oxidative stress via reducing excitotoxicity","volume":"9","author":"Odaka","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2025.117391_bb0235","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2741\/s310","article-title":"The role of mTOR signaling in Alzheimer disease","volume":"4","author":"Oddo","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.taap.2025.117391_bb0240","article-title":"Plumbagin induces G2\/M arrest, apoptosis, and autophagy via p38 MAPK-and PI3K\/Akt\/mTOR-mediated pathways in human tongue squamous cell carcinoma cells","volume":"9","author":"Pan","year":"2015","journal-title":"Drug Design"},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","article-title":"Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration","volume":"16","author":"Querfurth","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.taap.2025.117391_bb0250","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"Sci. World J."},{"issue":"10","key":"10.1016\/j.taap.2025.117391_bb0255","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/1570180817999200514100917","article-title":"Effect of Cabergoline on cognitive impairments in transgenic Drosophila model of Parkinson\u2019s disease","volume":"17","author":"Siddique","year":"2020","journal-title":"Lett. Drug Des. Discover."},{"issue":"6","key":"10.1016\/j.taap.2025.117391_bb0260","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3892\/ijmm.2017.2962","article-title":"The extracellular signal-regulated kinase 1\/2 pathway in neurological diseases: a potential therapeutic target","volume":"39","author":"Sun","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"10.1016\/j.taap.2025.117391_bb0265","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/iub.1099","article-title":"Transcriptional and post-transcriptional regulation of \u03b2-secretase","volume":"64","author":"Tamagno","year":"2012","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.taap.2025.117391_bb0270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41419-019-1526-0","article-title":"Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK\/EGR1 and AKT\/mTOR pathway respectively","volume":"10","author":"Tang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2025.117391_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-4159.2011.07477.x","article-title":"Identification and biology of \u03b1-secretase","volume":"120","author":"Vingtdeux","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2025.117391_bb0280","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1007\/s12035-021-02390-1","article-title":"The mTOR\/NF-\u03baB pathway mediates neuroinflammation and synaptic plasticity in diabetic encephalopathy","volume":"58","author":"Xu","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.taap.2025.117391_bb0285","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Centr. Nerv. Syst. Disease"},{"issue":"9","key":"10.1016\/j.taap.2025.117391_bb0290","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between a\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2025.117391_bb0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fneur.2014.00167","article-title":"Aluminum-induced amyloidogenesis and impairment in the clearance of amyloid peptides from the central nervous system in Alzheimer\u2019s disease","volume":"5","author":"Zhao","year":"2014","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.taap.2025.117391_bb0300","doi-asserted-by":"crossref","first-page":"F440","DOI":"10.1152\/ajprenal.00170.2006","article-title":"ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells","volume":"292","author":"Zhuang","year":"2007","journal-title":"American Journal of Physiology-Renal Physiology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2500167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2500167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:27:08Z","timestamp":1778473628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2500167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":60,"alternative-id":["S0041008X2500167X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117391","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of cabergoline to improve cognitive decline in D-galactose-injected ovariectomized rats: Modulation of AKT\/mTOR, GLT-1\/P38-MAPK, and ERK1\/2 signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117391"}}